Clinical Pearl: CCD care for HIV‐positive patients

○Compared with uninterrupted use of antiretroviral therapy, intermittent use increases the risk of opportunistic disease and death from any cause, including CVD. 10 ○There is increased cardiovascular risk in individuals with HIV, which is likely related to the adverse impact of antiretroviral treatments on lipid profiles. 11 ○It is recommended to choose newer generation antiretroviral treatment regimens associated with more favorable lipid and cardiovascular risk profiles, and less interaction with statins and other CCD medications. 12 ○Individuals with HIV and CVD should choose an alternative instead of an abacavir‐containing regimen because of its possible association with increased cardiovascular events. 13